You are here

  • Home
  • Archive
  • Volume 7, Issue 4
  • Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab

Article info

Article menu
Download PDFPDF
Colorectal
Case report
Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab

Authors

  1. Correspondence to Dr Saqib Mumtaz, Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham B152GW, UK; drsaqibmumtaz{at}gmail.com
View Full Text

Citation

Mumtaz S, Goh J, Hirschfield GM, et al
Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab
Frontline Gastroenterology 2016;7:271-274.

Publication history

  • First published August 5, 2016.
Online issue publication 
September 08, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/